ASCO 2019: Trial Update on Cytoreductive Nephrectomy for Intermediate-Risk Metastatic Renal Cancer
ASCO 2019: Enfortumab Vedotin in Advanced Urothelial Cancer
Dalantercept Plus Axitinib in Advanced Clear Cell Kidney Cancer
ASCO 2019: Does Adding Bevacizumab to Standard Treatment Improve Survival in Urothelial Carcinoma?
Monitoring Patients With Kidney Cancer for Cabozantinib-Related Toxicity
Is the Relationship Between Obesity and Outcomes in Kidney Cancer Sex-Specific?
Can Bladder Cancer Be Detected With a Urine Test?
Is Percutaneous Cryoablation a Viable Option for T1b Renal Cell Carcinoma?
Advanced Renal Cell Carcinoma: combination, sequential strategies, & immunotherapy
Optimizing Outcomes in mRCC: Finding the Balance of Immune Inhibition (login required)
Sequencing and Transitions for Advanced Renal Cell Carcinoma: Leveraging the Latest Tools and Managing Complications
Finding Answers to the Important Questions: Sequencing and Optimizing QoL in mRCC (login required)
Dana-Farber Cancer Institute - Find a Clinical Trial
The University of Texas MD Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
St. Jude Children's Research Hospital / The University of Tennessee Health Science Center
Nivolumab + Ipilimumab (Renal Cell Carcinoma)
Lenvatinib Plus Everolimus (Kidney Cancer)
Kidney Cancer Association
NCCN Guidelines for Patients Kidney Cancer—Quick Guide
American Cancer Society: Kidney Cancer